← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

Funds Holding in Top 10 Value Capital Flow New & Closed Increased & Reduced Calls & Puts Put/Call Ratio

New

Increased

Maintained

Reduced

Closed

Funds Holding 3,471

Funds Holding Change +10

Funds Holding Growth +0.3%

Value $641B

Holding in Top 10 415

Top 10 Change -46

Top 10 Growth -10%

Value Growth -0.2%

New 158

Increased 1,629

Reduced 1,445

Closed 109

Capital Inflow $15.5B

Capital Outflow $26B

Net Capital Flow -$10.5B

Capital Flow Change -$22.4B

Calls $6.55B

Puts $6.31B

Net Calls +$242M

Put/Call Ratio 0.96